Home | Business News | Browse by Publication | M | M2 Presswire

Market Commentary on CuraGen Corp.

Publication: M2 Presswire
Publication Date: 28-FEB-07
Format: Online
Delivery: Immediate Online Access

Article Excerpt
M2 PRESSWIRE-28 February 2007-Biotech News: Market Commentary on CuraGen Corp(C)1994-2007 M2 COMMUNICATIONS LTD

RDATE:28022007

Market Commentary on CuraGen Corp (NASDAQ:CRGN)

CuraGen sees cures in genes. The biotechnology firm uses its experience as a one-time gene researcher to discover and develop new therapies (including traditional small molecule drugs, as well as protein-based drugs and monoclonal antibodies) for a host of diseases, including cancer, inflammatory conditions, and metabolic disorders. Like many struggling development-stage firms, CuraGen partners with other companies to ease the burden of R&D costs. The company is working with Bayer to develop therapies for diabetes. With Abgenix it is creating fully human monoclonal antibodies for renal diseases. Seattle Genetics and TopoTarget are also key partners.

Shares were up...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from M2 Presswire
Supanet aiming for web hosting revolution., February 28, 2007
National Guard (In Federal Status) And Reserve Mobilized As Of Februar..., February 28, 2007
DISH Network and emuse absolutely offer ground-breaking interactive co..., February 28, 2007
In- Depth Research on Syntroleum Corp., February 28, 2007
Analysis of Nordson Corp., February 28, 2007

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.